) are lower on the session by 5.73%, currently trading at $27.16. The stock has been trading largely higher over the past six months, but cratered lower last week and is now testing the 200-day moving average. Options traders are buying protection on the name today. The August $27.50 strike was purchased 2,050 times, near the offer, on open interest of just 1,156 contracts. This signals new, bearish positioning. Put volume is now running at 3x the daily average. Lincare Holdings Inc. is a provider of oxygen and other respiratory therapy services to patients in the home. Its customers suffer from chronic obstructive pulmonary disease, such as emphysema, chronic bronchitis or asthma, and require supplemental oxygen or other respiratory therapy services. Lincare also provides a variety of durable medical equipment and home infusion therapies in certain geographic markets.